BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 23342042)

  • 1. Enhancement of auranofin-induced apoptosis in MCF-7 human breast cells by selenocystine, a synergistic inhibitor of thioredoxin reductase.
    Liu C; Liu Z; Li M; Li X; Wong YS; Ngai SM; Zheng W; Zhang Y; Chen T
    PLoS One; 2013; 8(1):e53945. PubMed ID: 23342042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo.
    Fan C; Zheng W; Fu X; Li X; Wong YS; Chen T
    Cell Death Dis; 2014 Apr; 5(4):e1191. PubMed ID: 24763048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species.
    Wang H; Bouzakoura S; de Mey S; Jiang H; Law K; Dufait I; Corbet C; Verovski V; Gevaert T; Feron O; Van den Berge D; Storme G; De Ridder M
    Oncotarget; 2017 May; 8(22):35728-35742. PubMed ID: 28415723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selenocysteine induces apoptosis in human glioma cells: evidence for TrxR1-targeted inhibition and signaling crosstalk.
    Fan CD; Fu XY; Zhang ZY; Cao MZ; Sun JY; Yang MF; Fu XT; Zhao SJ; Shao LR; Zhang HF; Yang XY; Sun BL
    Sci Rep; 2017 Jul; 7(1):6465. PubMed ID: 28743999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Anticancer Activity of Auranofin.
    Onodera T; Momose I; Kawada M
    Chem Pharm Bull (Tokyo); 2019; 67(3):186-191. PubMed ID: 30827998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auranofin, an inhibitor of thioredoxin reductase, induces apoptosis in hepatocellular carcinoma Hep3B cells by generation of reactive oxygen species.
    Hwang-Bo H; Jeong JW; Han MH; Park C; Hong SH; Kim GY; Moon SK; Cheong J; Kim WJ; Yoo YH; Choi YH
    Gen Physiol Biophys; 2017 Apr; 36(2):117-128. PubMed ID: 28218611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural borneol, a monoterpenoid compound, potentiates selenocystine-induced apoptosis in human hepatocellular carcinoma cells by enhancement of cellular uptake and activation of ROS-mediated DNA damage.
    Su J; Lai H; Chen J; Li L; Wong YS; Chen T; Li X
    PLoS One; 2013; 8(5):e63502. PubMed ID: 23700426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.
    Raninga PV; Di Trapani G; Vuckovic S; Tonissen KF
    Redox Biol; 2016 Aug; 8():175-85. PubMed ID: 26795735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance of S-nitrosothiol homeostasis plays an important role in growth suppression of estrogen receptor-positive breast tumors.
    Cañas A; López-Sánchez LM; Valverde-Estepa A; Hernández V; Fuentes E; Muñoz-Castañeda JR; López-Pedrera C; De La Haba-Rodríguez JR; Aranda E; Rodríguez-Ariza A
    Breast Cancer Res; 2012 Dec; 14(6):R153. PubMed ID: 23216744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morin enhances auranofin anticancer activity by up-regulation of DR4 and DR5 and modulation of Bcl-2 through reactive oxygen species generation in Hep3B human hepatocellular carcinoma cells.
    Hwang-Bo H; Lee WS; Nagappan A; Kim HJ; Panchanathan R; Park C; Chang SH; Kim ND; Leem SH; Chang YC; Kwon TK; Cheong JH; Kim GS; Jung JM; Shin SC; Hong SC; Choi YH
    Phytother Res; 2019 May; 33(5):1384-1393. PubMed ID: 30887612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic induction of apoptosis by combination treatment with mesupron and auranofin in human breast cancer cells.
    Lee JE; Kwon YJ; Baek HS; Ye DJ; Cho E; Choi HK; Oh KS; Chun YJ
    Arch Pharm Res; 2017 Jun; 40(6):746-759. PubMed ID: 28560500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selenocystine induces S-phase arrest and apoptosis in human breast adenocarcinoma MCF-7 cells by modulating ERK and Akt phosphorylation.
    Chen T; Wong YS
    J Agric Food Chem; 2008 Nov; 56(22):10574-81. PubMed ID: 18959417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation.
    Chen T; Wong YS
    Int J Biochem Cell Biol; 2009 Mar; 41(3):666-76. PubMed ID: 18718551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antineoplastic effects of auranofin in canine lymphoma cells.
    Zhang H; Rose BJ; Pyuen AA; Thamm DH
    BMC Cancer; 2018 May; 18(1):522. PubMed ID: 29724201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ruthenium(II) salicylate complexes inducing ROS-mediated apoptosis by targeting thioredoxin reductase.
    Chen JC; Zhang Y; Jie XM; She J; Dongye GZ; Zhong Y; Deng YY; Wang J; Guo BY; Chen LM
    J Inorg Biochem; 2019 Apr; 193():112-123. PubMed ID: 30711557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of thioredoxin reductase by auranofin induces apoptosis in adriamycin-resistant human K562 chronic myeloid leukemia cells.
    Liu JJ; Liu Q; Wei HL; Yi J; Zhao HS; Gao LP
    Pharmazie; 2011 Jun; 66(6):440-4. PubMed ID: 21699084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel organoarsenicals as robust thioredoxin reductase inhibitors for oxidative stress mediated cancer therapy.
    She W; Shi X; Liu T; Liu Y; Liu Y
    Biochem Pharmacol; 2023 Dec; 218():115908. PubMed ID: 37931662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of thioredoxin reductase (TrxR) triggers oxidative stress-induced apoptosis in filarial nematode Setaria cervi channelized through ASK-1-p38 mediated caspase activation.
    Joardar N; Sen A; Rath J; Babu SPS
    Mol Biochem Parasitol; 2021 Mar; 242():111364. PubMed ID: 33639230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer.
    Raninga PV; Lee AC; Sinha D; Shih YY; Mittal D; Makhale A; Bain AL; Nanayakarra D; Tonissen KF; Kalimutho M; Khanna KK
    Int J Cancer; 2020 Jan; 146(1):123-136. PubMed ID: 31090219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads.
    Kaminska KK; Bertrand HC; Tajima H; Stafford WC; Cheng Q; Chen W; Wells G; Arner ES; Chew EH
    Oncotarget; 2016 Jun; 7(26):40233-40251. PubMed ID: 27244886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.